Effect of Incretin Analogues and Dipeptidyl-peptidase-IV inhibitors on the risk of thyroid cancer

First published 18/10/2023

Last updated 27/03/2024

EU PAS number:

EUPAS107225

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

Effect of Incretin Analogs on risk of thyroid cancer

English (276.24 KB - PDF) View document

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Effect of Incretin Analogues and Dipeptidyl-peptidase-IV inhibitors on the risk of thyroid cancer

Secondary tabs

Share this page